Gad Berdugo

Gad Berdugo possesses extensive experience in the biotechnology sector, currently serving as a Strategy, Business & Corporate Development Advisor at Nutcracker Therapeutics, focusing on mRNA technology platform development. Additionally, Gad holds the position of Executive In Residence at Columbia Technology Ventures, facilitating the commercialization of biotechnology innovations and supporting startup efforts. As a Member of the Board of Directors at Evexta Bio and Managing Partner at Explorium Capital LLC, Gad engages in strategic advisory roles. Previous roles include Chief Business Officer at Editas Medicine, Chief Executive Officer and Co-Founder at EpiVax Therapeutics, and Chief Financial Officer at IMMUNE Pharmaceuticals. Gad's educational background includes an MBA from HEC Paris and advanced degrees in biotechnology and biochemical engineering.